Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-25 @ 3:08 AM
NCT ID:
NCT07265505
Eligibility Criteria:
Inclusion Criteria:
* Female aged ≥18 and \<36 years
* Undergoing assisted reproductive technology (ART) in a fertility center
* Covered by the French national health insurance system
* Belonging to one of two groups:
* Study group: history of recurrent implantation failure (RIF) and/or recurrent pregnancy loss (RPL)
* Control group: no history of RIF or RPL
Exclusion Criteria:
* Pregnant at inclusion
* Refusal to provide written informed consent
* Antibiotic use within one month prior to endometrial biopsy Positive serology for hepatitis B, hepatitis C or HIV
* Uterine anatomical abnormalities (e.g., polyps, cavity-distorting fibroids, untreated hydrosalpinx)
* Known chromosomal abnormality in either partner
* Known autoimmune disease, thrombophilia, or antiphospholipid antibody syndrome
* Persons under legal protection (e.g., guardianship, curatorship)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT07265505
Study Brief:
Protocol Section:
NCT07265505